Canopy Growth Corporation (NASDA: CGC) Q4 2021 earnings call dated June 01, 2021 Company Participants: Judy Hong -- Vice President, Investor Relations and Competitive Intelligence
Canopy Growth Corporation
-(CGC)
Get the latest Canopy Growth Corp. (CGC) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Canopy Growth Corporation (CGC) Q4 Earnings: Key financials and quarterly highlights
Canopy Growth Corporation (NYSE: CGC) reported fourth-quarter 2021 earnings results today. Net revenues increased 38% year-over-year to CAD $148 million. Net loss attributable
Canopy Growth Corporation (CGC) Q3 2021 Earnings Call Transcript
Canopy Growth Corporation (NYSE: CGC) Q3 2021 earnings call dated Feb. 09, 2021 Corporate Participants: Judy Hong -- Vice President of Investor Relations David
Canopy Growth Corporation (CGC) Q3 Earnings: Key financials and quarterly highlights
Canopy Growth Corporation (NYSE: CGC) reported Third quarter 2021 earnings results today. Net revenues increased 23% year-over-year to CAD $153 million. Net loss
Canopy Growth Corporation (CGC) Q2 Earnings: Key financials and quarterly highlights
Canopy Growth Corporation (NYSE: CGC) reported second quarter 2021 earnings results today. Net revenues increased 77% year-over-year to CAD135.3 million, driven by
Earnings calendar for the week of Nov. 9
Taking a cue from the presidential election, stock markets bounced back after ending the previous week on a low note. Major indexes
Canopy Growth’s (CGC) net loss narrows in Q1 on revenue growth and cost cuts; stock surges
After Canopy Growth (NYSE: CGC) reported its first quarter 2021 results yesterday, the shares jumped about 10% in the pre-market trading and
Canopy Growth (CGC) Q1 2021 earnings in a nutshell
Canopy Growth (NYSE: CGC) reported an improvement in net loss for its first quarter ended 2021 with a revenue increase of 22%.
With right product mix and CAPEX discipline, Canopy Growth (CGC) can hit growth path
The latest quarterly performance of Canopy Growth Corporation (NYSE: CGC) was nothing short of a disaster, with the cannabis firm incurring a
Infographic: Highlights of Canopy Growth (CGC) Q4 2020 earnings results
Canopy Growth Corporation (NYSE: CGC) reported its financial results for the quarter ended March 31, 2020, on Friday before the market opens.
Canopy Growth (CGC) slips to Q3 loss; stock surges on strong revenue growth
Presenting the first quarterly report under its new CEO, Canopy Growth Corporation (NYSE: CGC) posted a net loss for the third quarter
Earnings Preview: Headwinds expected to dampen Canopy Growth’s (CGC) Q3 performance
Canadian-based major pot producer Canopy Growth (NYSE: CGC) (TSX: WEED) is poised to publish its third quarter 2020 earnings results tomorrow early morning.
Why Canopy Growth (CGC) might put investors in high spirits this year
For the cannabis industry, 2019 was a tough year though most companies started it on an optimistic note. With the year coming
Canopy Growth (NYSE: CGC) posts wider-than-expected loss in Q2
Canopy Growth (NYSE: CGC) (TSX: WEED) reported a wider loss for the second quarter of 2020 due to higher costs and expenses.
Canopy Growth (NYSE: CGC) likely to lose in Q2 earnings battle on Nov 14
Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is slated to report its second-quarter 2020 earnings results on Thursday before the market opens.
Aphria, Canopy Growth, Aurora Cannabis bow to pressure from vaping fatalities
Leading players in the cannabis industry were bleeding on Monday after the Centers for Disease Control and Prevention (CDC) revealed that it
Aurora, Canopy Growth to be the biggest gainers in Cannabis 2.0
Both Aurora Cannabis (NYSE: ACB) and Canopy Growth Corporation (NYSE: CGC) have reported disappointing quarterly results in the most recent quarter. Share
Pot giants gain on DEA announcement; GW Pharmaceuticals continues to decline
Marijuana giants received a major boost on Monday after the US Drug Enforcement Administration (DEA) announced that it would initiate steps to
DEEP FOCUS: Everything you need to know about GW Pharmaceuticals
Shares of GW Pharmaceuticals (NASDAQ: GWPH) have gained 72% in the year-to-date period, emerging as a new favorite among pot investors. However,
Earnings: Canopy Growth posts big Q4 miss, but investors remain stoic
Canopy Growth (NYSE: CGC) reported a loss of CAD 0.98 per share on revenues of CAD 94.1 million in the fourth quarter,
Earnings preview: Will Canopy Growth post upbeat Q4 2019 results?
Canopy Growth (TSX: WEED, NYSE: CGC) is scheduled to release its financial results for the fourth fiscal quarter of 2019 after the